4-[(3-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzenesulfonamide;ethane
C24H26N6O2S — CID 143251460
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(3-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzenesulfonamide;ethane
4-[(3-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzenesulfonamide;ethane (PubChem CID 143251460) has the molecular formula C24H26N6O2S and a molecular weight of 462.58 g/mol. Its IUPAC name is 4-[(3-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzenesulfonamide;ethane.
Molecular Properties
| Compound Name | 4-[(3-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzenesulfonamide;ethane |
|---|---|
| PubChem CID | 143251460 |
| Molecular Formula | C24H26N6O2S |
| Molecular Weight | 462.58 g/mol |
| Exact Mass | 462.18 |
| IUPAC Name | 4-[(3-cyano-2-methyl-5-phenylpyrazolo[1,5-a]pyrimidin-7-yl)amino]-N,N-dimethylbenzenesulfonamide;ethane |
| SMILES | CC.Cc1nn2c(Nc3ccc(S(=O)(=O)N(C)C)cc3)cc(-c3ccccc3)nc2c1C#N |
| InChI | InChI=1S/C22H20N6O2S.C2H6/c1-15-19(14-23)22-25-20(16-7-5-4-6-8-16)13-21(28(22)26-15)24-17-9-11-18(12-10-17)31(29,30)27(2)3;1-2/h4-13,24H,1-3H3;1-2H3 |
| InChIKey | MNDUIVHITQVQFW-UHFFFAOYSA-N |
| XLogP | 4.60 |
| TPSA | 103.39 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 462.58 |
| LogP ≤ 5 | 4.60 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143251460 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.